These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

796 related articles for article (PubMed ID: 27122671)

  • 1. Lymphocyte-to-monocyte ratio predicts survival after radiofrequency ablation for colorectal liver metastases.
    Facciorusso A; Del Prete V; Crucinio N; Serviddio G; Vendemiale G; Muscatiello N
    World J Gastroenterol; 2016 Apr; 22(16):4211-8. PubMed ID: 27122671
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lymphocyte-to-monocyte ratio predicts survival of patients with hepatocellular carcinoma after curative resection.
    Lin ZX; Ruan DY; Li Y; Wu DH; Ma XK; Chen J; Chen ZH; Li X; Wang TT; Lin Q; Wen JY; Wu XY
    World J Gastroenterol; 2015 Oct; 21(38):10898-906. PubMed ID: 26478681
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic role of 25-hydroxyvitamin D in patients with liver metastases from colorectal cancer treated with radiofrequency ablation.
    Facciorusso A; Del Prete V; Muscatiello N; Crucinio N; Barone M
    J Gastroenterol Hepatol; 2016 Aug; 31(8):1483-8. PubMed ID: 26896637
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of selected inflammation-based prognostic markers in relapsed or refractory metastatic colorectal cancer patients.
    Song A; Eo W; Lee S
    World J Gastroenterol; 2015 Nov; 21(43):12410-20. PubMed ID: 26604648
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Preoperative Lymphocyte-to-Monocyte Ratio is Prognostic of Clinical Outcomes for Patients with Liver-Only Colorectal Metastases in the Neoadjuvant Setting.
    Neofytou K; Smyth EC; Giakoustidis A; Khan AZ; Williams R; Cunningham D; Mudan S
    Ann Surg Oncol; 2015 Dec; 22(13):4353-62. PubMed ID: 25773876
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of outcomes and treatment safety of patients with metastatic colorectal cancer to the liver with estimation of prognostic factors.
    Zeman M; Maciejewski A; Półtorak S; Kryj M
    Pol Przegl Chir; 2013 Jun; 85(6):333-9. PubMed ID: 23828415
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic significance of the lymphocyte-to-monocyte ratio in patients with metastatic colorectal cancer.
    Shibutani M; Maeda K; Nagahara H; Ohtani H; Sakurai K; Yamazoe S; Kimura K; Toyokawa T; Amano R; Tanaka H; Muguruma K; Hirakawa K
    World J Gastroenterol; 2015 Sep; 21(34):9966-73. PubMed ID: 26379401
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Post-ablation des-gamma-carboxy prothrombin level predicts prognosis in hepatitis B-related hepatocellular carcinoma.
    Lee S; Rhim H; Kim YS; Kang TW; Song KD
    Liver Int; 2016 Apr; 36(4):580-7. PubMed ID: 26503910
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of pulmonary colorectal metastases by radiofrequency ablation.
    Petre EN; Jia X; Thornton RH; Sofocleous CT; Alago W; Kemeny NE; Solomon SB
    Clin Colorectal Cancer; 2013 Mar; 12(1):37-44. PubMed ID: 23026111
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pretreatment lymphocyte-monocyte ratio as a potential prognostic factor in a cohort of patients with upper tract urothelial carcinoma.
    Hutterer GC; Sobolev N; Ehrlich GC; Gutschi T; Stojakovic T; Mannweiler S; Pummer K; Zigeuner R; Pichler M; Dalpiaz O
    J Clin Pathol; 2015 May; 68(5):351-5. PubMed ID: 25661796
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictive factors for time to recurrence, treatment and post-recurrence survival in patients with initially resected colorectal liver metastases.
    Angelsen JH; Viste A; Løes IM; Eide GE; Hoem D; Sorbye H; Horn A
    World J Surg Oncol; 2015 Dec; 13():328. PubMed ID: 26631156
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CALy Prognostic Score (CEA, ALP, Lymphocyte Count) as a predictor of survival after hepatectomy for liver-only colorectal metastases.
    Neofytou K; Giakoustidis A; Mudan S
    J BUON; 2015; 20(3):746-55. PubMed ID: 26214626
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Lymphocyte-to-Monocyte Ratio is a Superior Predictor of Overall Survival in Comparison to Established Biomarkers of Resectable Colorectal Cancer.
    Chan JC; Chan DL; Diakos CI; Engel A; Pavlakis N; Gill A; Clarke SJ
    Ann Surg; 2017 Mar; 265(3):539-546. PubMed ID: 27070934
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical scenarios associated with local recurrence after laparoscopic radiofrequency thermal ablation of colorectal liver metastases.
    Aksoy E; Aliyev S; Taskin HE; Birsen O; Mitchell J; Siperstein A; Berber E
    Surgery; 2013 Oct; 154(4):748-52; discussion 752-4. PubMed ID: 24074411
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatectomy vs radiofrequency ablation for colorectal liver metastasis: a propensity score analysis.
    Lee H; Heo JS; Cho YB; Yun SH; Kim HC; Lee WY; Choi SH; Choi DW
    World J Gastroenterol; 2015 Mar; 21(11):3300-7. PubMed ID: 25805937
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Evaluation value of preoperative peripheral blood lymphocyte-to-monocyte ratio on the prognosis of patients with stage III colon cancer].
    Chen J; Peng J; Fan W; Zhang R; Wang F; Zhou W; Xu D; Pan Z; Lu Z
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Jan; 22(1):73-78. PubMed ID: 30703797
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum ferritin as a new prognostic factor in hepatocellular carcinoma patients treated with radiofrequency ablation.
    Facciorusso A; Del Prete V; Antonino M; Neve V; Crucinio N; Di Leo A; Carr BI; Barone M
    J Gastroenterol Hepatol; 2014 Nov; 29(11):1905-10. PubMed ID: 24731153
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patterns of recurrence following selective intraoperative radiofrequency ablation as an adjunct to hepatic resection for colorectal liver metastases.
    Eltawil KM; Boame N; Mimeault R; Shabana W; Balaa FK; Jonker DJ; Asmis TR; Martel G
    J Surg Oncol; 2014 Nov; 110(6):734-8. PubMed ID: 24965163
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined resection and RFA in colorectal liver metastases: stratification of long-term outcomes.
    Sasaki K; Margonis GA; Andreatos N; Kim Y; Wilson A; Gani F; Amini N; Pawlik TM
    J Surg Res; 2016 Nov; 206(1):182-189. PubMed ID: 27916360
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determinants of survival after liver resection for metastatic colorectal carcinoma.
    Parau A; Todor N; Vlad L
    J BUON; 2015; 20(1):68-77. PubMed ID: 25778299
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 40.